D. Boral Capital has maintained a Buy recommendation for MediciNova (MNOV). The average one-year price target suggests a 357.69% upside, with institutional ownership showing some increases in certain funds, though overall shares owned by institutions decreased. The put/call ratio indicates a bullish outlook for the stock.

美第奇新星生物技术

<p>D. Boral Capital 对 MediciNova (MNOV) 维持了买入评级。平均一年价格目标显示出 357.69% 的上涨空间，尽管整体机构持股减少，但某些基金的机构持股有所增加。看跌/看涨比率表明对该股票的看涨前景</p>

D. Boral Capital 维持对美第奇新星生物技术（MediciNova，MNOV）的买入建议